Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future

  • ID: 4036082
  • Report
  • Region: Global
  • 61 Pages
  • Frost & Sullivan
1 of 3
Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market

This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosion of new approval applications, consolidation, and globalization of both small and large molecule industries. Also, with the continuous growth of biologics, the global pharmaceutical stability testing market is expected to witness robust growth.

Biologics stability testing, being more complicated than that of small molecules, is expected to contribute significantly to overall revenue. Biopharmaceutical companies are consolidating stability storage and limiting testing to one facility whereas pharmaceutical companies are moving toward decentralized stability testing, and centralized management and reporting. These companies are opting for single stability storage deals and building strategic relationships with CROs. Also, they are looking for end-to-end services to outsource the entire development project to a single CRO.

Early-stage biotech is identified as the largest growth segment for stability services, and has posted the highest increase during the past few years. For new-generation therapies and new trends in formulations such as non-aqueous and liposomal, many original study strategies apply but new strategies need to be adopted to deal with some of the nuances. Asia-Pacific, especially India and China, is emerging as a big growth opportunity area for this market. Several large CROs are exploring acquisitions here. Many local participants in these markets provide specialized services for global participants. There is also high demand for stability testing for such products in the local markets.

READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Executive Summary

2. Key Findings

3. Scope and Segmentation
  • Stability Testing in Biologics and Pharmaceutical Development Cycle
  • Stability Testing Phases
  • Trends in Global Pharmaceutical Stability Testing Market
4. Market Overview
  • Global Market Perspective
  • Factors Affecting Drug Product Stability
  • ICH-Recommended Stability Study Conditions
  • ICH Climate Stability Zones
5. Market Revenue Forecast
  • Revenue Forecast
  • Revenue Forecast Discussion
6. Trends in Pharmaceutical Stability Testing Outsourcing
  • Benefits of Outsourcing Stability Testing Services
  • In-house and Outsourcing Stability Studies
7. Trends in Pharmaceutical Stability Testing-Small and Large Molecules
  • Small and Large Molecules Stability Testing Segment
  • Small and Large Molecules Stability Testing Segment Size
8. Regional Trends in Stability Testing
  • Regional Trends in Pharmaceutical Stability Testing
9. Key Technology Trends
  • New Therapies
  • New Therapy Challenges
  • Trends in Formulations
10. Analysis of Customer Base
  • Customer Base Analysis for Stability Testing
  • Collaborations between CROs and Customers
  • Voice of Customer-Key Requirements Before and After Outsourcing Stability Studies
  • Voice of Customer-Requirements from Contract Service Providers or Unmet Market Needs
11. Growth Opportunities
  • Growth Opportunities for the Pharmaceutical Stability Testing Market
12. Company Profiles
  • Charles River Laboratories
  • Eurofins Scientific
  • Intertek
  • BioReliance
13. Geographical Breakdown of Other Major Competitors -
  • North America
  • Europe
  • Asia-Pacific
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll